High rate of complete remisions (CR) with concomitant chemoradiotherapy (QRT) in esophageal cancer (EC).: Preliminary results in a phase II trial.

被引：0
|
作者：
Balmana, J
Brunet, J
Balart, J
Rodriguez, MR
Montesinos, J
Rius, X
Gallen, M
Arcusa, A
Pardo, B
Marcuello, E
López, JJL
机构：
[1] Hosp St Pau, Med Oncol Serv, Barcelona, Spain
[2] Hosp St Pau, Serv Radioterapia, Barcelona, Spain
[3] Hosp St Pau, Serv Cirugia, Barcelona, Spain
[4] Hosp Del Mar, Serv Oncol, Barcelona, Spain
[5] Gen Hosp, Terrassa, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [41] The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial
    Brenner, Baruch
    Purim, Ofer
    Gordon, Noa
    Goshen-Lago, Tal
    Idelevich, Efraim
    Kashtan, Hanoch
    Menasherov, Nikolai
    Fenig, Eyal
    Sulkes, Aaron
    Kundel, Yulia
    RADIOTHERAPY AND ONCOLOGY, 2019, 134 : 74 - 80
  • [42] Oxaliplatin and irinotecan chemotherapy in advanced gastric cancer.: Final results of a multicenter phase II trial.
    Woell, E.
    Kuehr, T.
    Eisterer, W.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Hilbe, W.
    Thaler, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 195S - 195S
  • [43] Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial.
    Sebag-Montefiore, D.
    Steele, R.
    Quirke, P.
    Grieve, R.
    Khanna, S.
    Monson, J.
    Holliday, A.
    Thompson, L.
    Griffiths, G.
    Stephens, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 148S - 148S
  • [44] Randomized phase II trial comparing therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: Preliminary results of the feasibility of the SHIVA trial.
    Le Tourneau, Christophe
    Scholl, Suzy
    Mitrv, Emmanuel
    Isambert, Nicolas
    Tredan, Olivier
    Delord, Jean-Pierre
    Goncalves, Antony
    Campone, Mario
    Gavoille, Celine
    Servois, Vincent
    Mariani, Odette
    Vincent-Salomon, Anne
    Gentien, David
    Frio, Thomas Rio
    Servant, Nicolas
    Romejon, Julien
    Bieche, Ivan
    Delattre, Olivier
    Paoletti, Xavier
    Kamal, Maud
    CANCER RESEARCH, 2013, 73 (08)
  • [45] Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer
    Swisher, SG
    Ajani, JA
    Komaki, R
    Nesbitt, JC
    Correa, AM
    Cox, JD
    Lahoti, S
    Martin, F
    Putnam, JB
    Smythe, WR
    Vaporciyan, AA
    Walsh, GL
    Roth, JA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (01): : 120 - 127
  • [46] A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer
    Hyun Chang
    Sung Kwan Shin
    Byoung Chul Cho
    Chang-Geol Lee
    Choong Bai Kim
    Dae Joon Kim
    Jin Gu Lee
    Jin Hur
    Chang Young Lee
    Mi Kyung Bae
    Hye Ryun Kim
    Sang Kil Lee
    Jun Chul Park
    Hyuk Lee
    Hyoung-Il Kim
    Hyunsoo Chung
    Jihye Cha
    Yong Chan Lee
    Joo-Hang Kim
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 665 - 671
  • [47] Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
    Pera, M.
    Gallego, R.
    Montagut, C.
    Martin-Richard, M.
    Iglesias, M.
    Conill, C.
    Reig, A.
    Balague, C.
    Petriz, L.
    Momblan, D.
    Bellmunt, J.
    Maurel, J.
    ANNALS OF ONCOLOGY, 2012, 23 (03) : 664 - +
  • [48] A PHASE-II TRIAL OF NEOADJUVANT CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER
    GRADISHAR, WJ
    HARAF, DJ
    HOFFMAN, PC
    RADEMAKER, AW
    FERGUSON, MK
    GOLOMB, H
    BITRAN, JD
    VOKES, EE
    ONCOLOGY REPORTS, 1994, 1 (05) : 957 - 962
  • [49] A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer
    Chang, Hyun
    Shin, Sung Kwan
    Cho, Byoung Chul
    Lee, Chang-Geol
    Kim, Choong Bai
    Kim, Dae Joon
    Lee, Jin Gu
    Hur, Jin
    Lee, Chang Young
    Bae, Mi Kyung
    Kim, Hye Ryun
    Lee, Sang Kil
    Park, Jun Chul
    Lee, Hyuk
    Kim, Hyoung-Il
    Chung, Hyunsoo
    Cha, Jihye
    Lee, Yong Chan
    Kim, Joo-Hang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 665 - 671
  • [50] Two-fraction carbon ion radiotherapy for hepatocellular carcinoma: Preliminary results of a phase I/II clinical trial.
    Kato, H
    Yamada, S
    Yasuda, S
    Yamaguchi, K
    Kitabayashi, H
    Kamada, T
    Mizoe, JE
    Ohto, M
    Tsujii, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 338S - 338S
12345